FUJISAWA IS JAPAN'S SEVENTH-LARGEST PHARMACEUTICAL COMPANY. IT SEL...

78. Fujisawa is Japan's seventh-largest pharmaceutical company. It sells drugs for organ transplant patients

to increase the probability the new organ will operate efficiently and not be rejected. Currently, the

only products Fujisawa makes are these organ transplant drugs, which it sells worldwide. Its patents

protect it from competitors. Fujisawa has a:

a. brand name advantage

b. niche competitive advantage

c. cost competitive advantage

d. marketing competitive advantage

e. complete competitive advantage

ANS: B

A niche competitive advantage is the advantage achieved when a firm seeks to target and effectively

serve a small segment of the market, in this case people who need organ transplant drugs.

PTS: 1

REF: 35-36

OBJ: 02-6

TOP: AACSB Reflective Thinking

KEY: CB&E Model Strategy

MSC: BLOOMS Level III Application